文献速递急性肾损伤慢性肾脏病

奎宁诱导的血栓性微血管病:19例患者报告

Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
PubMed 文献 · Am J Kidney Dis · 2017-08-03

该病例系列描述了19例奎宁诱导的血栓性微血管病(TMA)患者的临床特征和长期结局。所有患者均表现为微血管病性溶血性贫血、血小板减少和急性肾损伤,初始均被误诊为TTP或HUS。17例需要透析,14例发展为慢性肾脏病,8例死亡。

要点

  • 奎宁可诱导TMA,表现为微血管病性溶血性贫血、血小板减少和急性肾损伤。
  • 所有患者初始均被误诊为TTP或HUS,奎宁不良反应未被怀疑。
  • 17/18存活患者需要透析,14例发展为CKD,8例死亡。

核心结论

  • 奎宁诱导的TMA导致严重急性肾损伤,常进展为慢性肾脏病。

研究设计与样本

  • 病例系列,19例奎宁诱导的TMA患者,均接受血浆置换治疗。
  • 患者来自俄克拉荷马TTP-HUS登记处,1989-2015年共509例。

主要发现

  • 18例检测到奎宁依赖性抗体与血小板和/或中性粒细胞反应,8例有奎宁相关全身症状史。
  • 所有患者均有微血管病性溶血性贫血、血小板减少和急性肾损伤,初始均误诊为TTP或HUS。
  • 1例治疗前死亡;18例存活者中17例需要透析;14例发展为慢性肾脏病,其中3例终末期肾病;8例死亡。

关键数值与推荐

  • 19/509例(1989-2015年登记)为奎宁诱导的TMA。
  • 18例为女性,所有患者均为白人;18例通过药片暴露,1例通过汤力水暴露。

临床怎么用

  • 对表现为TMA和急性肾损伤的患者,应询问奎宁暴露史以避免误诊为TTP或HUS。
  • 奎宁诱导的TMA患者常需要透析,应监测肾功能长期恢复情况。

局限性

  • 未识别未请求血浆置换的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Quinine can cause diverse and severe immune-mediated adverse reactions, including thrombotic microangiopathy (TMA). Our objective was to describe the presenting features and long-term outcomes of patients with quinine-induced TMA. STUDY DESIGN: A case series of 19 patients with quinine-induced TMA treated with plasma exchange. SETTING & PARTICIPANTS: Patients with quinine-induced TMA initially suspected of having thrombotic thrombocytopenic purpura (TTP) were identified among patients enrolled in the Oklahoma TTP-Hemolytic Uremic Syndrome Registry. OUTCOMES: The clinical course of the initial episode and morbidity and mortality following recovery. MEASUREMENTS: The diagnosis of quinine-induced TMA was confirmed by documentation of quinine-dependent antibodies reactive with platelets or neutrophils and/or by previous quinine-associated systemic symptoms. Clinical data from the initial episode and long-term follow-up were described, focusing on kidney function. RESULTS: 19 of the 509 patients enrolled in the registry in 1989 to 2015 had quinine-induced TMA. 18 patients had quinine-dependent antibodies reactive with platelets and/or neutrophils (1 patient died before testing); 8 patients had a history of quinine-associated systemic symptoms. All patients were white; 18 were women. Quinine exposure was in pill form for 18 patients and as tonic water for 1. All patients had microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. All were initially misdiagnosed as having TTP or hemolytic uremic syndrome, and adverse reactions to quinine were not initially suspected. 1 patient died before treatment began; 17 of the 18 surviving patients required dialysis. 14 patients developed chronic kidney disease, 3 of whom developed end-stage renal disease. 8 patients died. LIMITATIONS: Patients for whom plasma exchange was not requested were not identified. CONCLUSIONS: Quinine-induced TMA causes severe acute kidney injury that commonly results in chronic kidney disease.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Page EE, Little DJ, Vesely SK, et al. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Am J Kidney Dis. 2017. PMID: 28780041. doi:10.1053/j.ajkd.2017.05.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。